CNFG
ABBV icon

Creegan & Nassoura Financial Group’s AbbVie ABBV Stock Holding History

Creegan & Nassoura Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-22,245
Closed -$1.3M – 76
2015
Q1 		$1.3M Sell
22,245
-1,699
-7% -$103K 1.34% 34
2014
Q4 		$1.57M Buy
+23,944
New +$1.51M 1.6% 28

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Creegan & Nassoura Financial Group's ABBV Position: Q2 2015 in Review

Creegan & Nassoura Financial Group sold out of AbbVie (ABBV) in Q2 2015, closing a stake of 22,245 shares — an estimated $1.3M sold.

Creegan & Nassoura Financial Group first reported a position in ABBV in Q4 2014 and held it in 2 quarters. The position peaked at $1.57M in Q4 2014. 1,652 funds tracked by Wall St. Rank hold ABBV as of Q2 2015.

  • Creegan & Nassoura Financial Group reported no remaining AbbVie position as of Q2 2015 after selling out during the quarter.
  • Creegan & Nassoura Financial Group sold 22,245 AbbVie shares in Q2 2015, an estimated $1.3M.
  • Creegan & Nassoura Financial Group first reported a position in AbbVie in Q4 2014 and held it in 2 quarters.
  • Creegan & Nassoura Financial Group's AbbVie position peaked at $1.57M in Q4 2014.
  • 1,652 funds tracked by Wall St. Rank held AbbVie as of Q2 2015.

Based on Creegan & Nassoura Financial Group's 13F filing for Q2 2015, filed 14 Aug 2015.